Optimization of Guideline-Directed Medical Therapy and Volume Stability Using an AI-Enabled Virtual Heart Failure Care Platform Across Community Cardiology Practices

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - AstraZenca; Fire1; Bayer AG; Pfizer; Ensho Health; Acorai; novo nordisk</li><li>Equity/Stock(s)/Options - Apricity Robotics; Kilele Health</li><li>Grant Support/Research Contract - Heart Failure Society of America (HFSA); Edwards Lifesciences</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Dyania Health</li></ul>